Human CD4+CD25+ regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine/paracrine inhibitory functional loop.

作者: Marco Cosentino , Anna Maria Fietta , Marco Ferrari , Emanuela Rasini , Raffaella Bombelli

DOI: 10.1182/BLOOD-2006-01-028423

关键词:

摘要: CD4+CD25+ regulatory T lymphocytes (Tregs) are specialized cells playing a key role in the control of immune homeostasis. Here, we show that human Tregs constitutively express tyrosine hydroxylase (TH, EC 1.14.16.2), rate-limiting enzyme synthesis catecholamines, and contain substantial amounts dopamine, norepinephrine, epinephrine, which released upon treatment with reserpine. Catecholamine release results reduced production interleukin-10 transforming growth factor-beta by Tregs, down-regulation Treg-dependent inhibition effector T-lymphocyte (Teff) proliferation, occurs without affecting tumor necrosis factor-alpha or interferon-gamma. Teffs on cell membrane both D1-like D2-like dopaminergic receptors to similar extent (12%-29% cells). Catecholamine-dependent is, however, selectively reversed pharmacological blockade receptors, only (and not Teffs) also expressed at level mRNA functionally coupled intracellular cAMP. These findings indicate endogenous catecholamines subserve an autocrine/paracrine loop involving pathways resulting Treg function.

参考文章(63)
Stergios Moschos, Sai Varanasi, John M. Kirkwood, Interferons in the Treatment of Solid Tumors Cancer treatment and research. ,vol. 126, pp. 207- 241 ,(2005) , 10.1007/0-387-24361-5_9
Steven L. Kunkel, Robert N. Spengler, Stephen W. Chensue, Nicole Blenk, Donald A. Giacherio, Endogenous norepinephrine regulates tumor necrosis factor-alpha production from macrophages in vitro. Journal of Immunology. ,vol. 152, pp. 3024- 3031 ,(1994)
Yoshiko Watanabe, Takashi Nakayama, Daisuke Nagakubo, Kunio Hieshima, Zhe Jin, Fuminori Katou, Kenji Hashimoto, Osamu Yoshie, Dopamine Selectively Induces Migration and Homing of Naive CD8+ T Cells via Dopamine Receptor D3 Journal of Immunology. ,vol. 176, pp. 848- 856 ,(2006) , 10.4049/JIMMUNOL.176.2.848
David M Segal, Carlos T Moraes, Deborah C Mash, Up-regulation of D3 dopamine receptor mRNA in the nucleus accumbens of human cocaine fatalities Molecular Brain Research. ,vol. 45, pp. 335- 339 ,(1997) , 10.1016/S0169-328X(97)00025-9
Y. Nagai, S. Ueno, Y. Saeki, F. Soga, M. Hirano, T. Yanagihara, Decrease of the D3 dopamine receptor mRNA expression in lymphocytes from patients with Parkinson's disease Neurology. ,vol. 46, pp. 791- 795 ,(1996) , 10.1212/WNL.46.3.791
N R Musso, S Brenci, M Setti, F Indiveri, G Lotti, Catecholamine content and in vitro catecholamine synthesis in peripheral human lymphocytes The Journal of Clinical Endocrinology and Metabolism. ,vol. 81, pp. 3553- 3557 ,(1996) , 10.1210/JCEM.81.10.8855800
Sheila L. Vrana, Bryan W. Kluttz, Kent E. Vrana, Application of quantitative RT-PCR to the analysis of dopamine receptor mRNA levels in rat striatum Molecular Brain Research. ,vol. 34, pp. 127- 134 ,(1995) , 10.1016/0169-328X(95)00152-I
Robert W. McMurray, Bromocriptine in rheumatic and autoimmune diseases Seminars in Arthritis and Rheumatism. ,vol. 31, pp. 21- 32 ,(2001) , 10.1053/SARH.2001.25482